Sunitinib monotherapy instead of mitotane combination therapy for the treatment of refractory adrenocortical carcinoma

E-ISSN： 1442-2042|22|11|1079-1081

ISSN： 0919-8172

Source： INTERNATIONAL JOURNAL OF UROLOGY, Vol.22, Iss.11, 2015-11, pp. : 1079-1081

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Embolization in an Adrenocortical Carcinoma as Palliative Therapy

Oncology Research and Treatment, Vol. 22, Iss. 6, 2000-01 ,pp. : 513-516

Karger

Access to resources Recommend Favorite

Gemcitabine Monotherapy as Second-Line Treatment in Cisplatin-Refractory Transitional Cell Carcinoma – Prognostic Factors for Response and Improvement of Quality of Life

Oncology Research and Treatment, Vol. 25, Iss. 1, 2002-03 ,pp. : 47-52

Karger

Access to resources Recommend Favorite

Long-Term Efficacy of Entecavir Plus Adefovir Combination Therapy versus Entecavir Monotherapy in Adefovir Refractory Chronic Hepatitis B Patients with Prior Lamivudine Resistance

Intervirology, Vol. 57, Iss. 1, 2013-08 ,pp. : 8-16

Karger

Access to resources Recommend Favorite

Combination therapy incorporating Bcl‐2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14)

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 2018-02 ,pp. : 215-217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry

By Weaver Arthur L. Lautzenheiser Richard L. Schiff Michael H. Gibofsky Allan Perruquet James L. Luetkemeyer John Paulus Harold E. Xia H Amy Leff Jonathan A.

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 185-198

Informa Healthcare

Access to resources Recommend Favorite